Managers / Q2 2019 · view latest →
Telemetry Investments, L.L.C.
CIK 0001537055 · 152 WEST 36TH STREET, ROOM 402, NEW YORK, NY, 10018-8765 · 212-425-9700
Summary
Telemetry Investments, L.L.C. reported $129M in U.S.-listed holdings across 82 positions for Q2 2019.
Its largest position, KDMN, represents 3.2% of the portfolio.
Compared with Q1 2019, the fund opened 32 new positions and exited 49.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 48.9% · $63M
- Common Stock · 41.5% · $54M
- Other · 4.8% · $6M
- US DOMESTIC · 2.3% · $3M
- MLP · 2.1% · $3M
- REIT · 0.5% · $591,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ISHARES TR | NEW | +75.0K | 75.0K | +$9M | $9M |
| MCKMCKESSON CORP | NEW | +40.0K | 40.0K | +$5M | $5M |
| WELLCARE HEALTH PLANS INC | NEW | +7.5K | 7.5K | +$2M | $2M |
| VERSUM MATLS INC | NEW | +41.0K | 41.0K | +$2M | $2M |
| APHRIA INC | NEW | +200.0K | 200.0K | +$1M | $1M |
| WPX ENERGY INC | NEW | +100.0K | 100.0K | +$1M | $1M |
| BUCKEYE PARTNERS L P | NEW | +27.0K | 27.0K | +$1M | $1M |
| PARATEK PHARMACEUTICALS INC | NEW | +1.50M | 1.50M | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | KDMNKADMON HLDGS INChistory → | COM | 3.20% | $4M | 2.01M |
| 2 | EIGER BIOPHARMACEUTICALS INC | COM | 3.08% | $4M | 376.0K |
| 3 | RED HAT INC | COM | 1.81% | $2M | 12.5K |
| 4 | XTNTXTANT MED HLDGS INChistory → | COM NEW | 1.81% | $2M | 782.4K |
| 5 | WELLCARE HEALTH PLANS INC | COM | 1.65% | $2M | 7.5K |
| 6 | VERSUM MATLS INC | COM | 1.63% | $2M | 41.0K |
| 7 | ZOSANO PHARMA CORP | COM NEW | 1.60% | $2M | 634.0K |
| 8 | AFFIMED N V | COM | 1.52% | $2M | 684.0K |
| 9 | WABCO HLDGS INC | COM | 1.29% | $2M | 12.6K |
| 10 | OAKTREE CAP GROUP LLC | UNIT CL A | 1.21% | $2M | 31.5K |
| 11 | VERASTEM INC | NOTE 5.000%11/0 · COM | 1.10% | $1M | 2.47M |
| 12 | GLDSPDR GOLD TRUST | GOLD SHS | 0.91% | $1M | 8.8K |
| 13 | TRCOTRIBUNE MEDIA CO | CL A | 0.89% | $1M | 25.0K |
| 14 | BUCKEYE PARTNERS L P | UNIT LTD PARTN | 0.86% | $1M | 27.0K |
| 15 | PARATEK PHARMACEUTICALS INC | NOTE 4.750% 5/0 | 0.78% | $1M | 1.50M |
| 16 | MULTI COLOR CORP | COM | 0.74% | $964,000 | 19.3K |
| 17 | GLOBAL BRASS & COPPR HLDGS I | COM | 0.72% | $937,000 | 21.4K |
| 18 | EL PASO ELEC CO | COM NEW | 0.66% | $850,000 | 13.0K |
| 19 | DERMIRA INC | COM | 0.59% | $760,000 | 79.5K |
| 20 | GLOBALSTAR INC | COM | 0.57% | $736,000 | 1.53M |
| 21 | VRAYQVIEWRAY INC | COM | 0.53% | $683,000 | 77.5K |
| 22 | FNSRFINISAR CORP | COM NEW | 0.49% | $640,000 | 28.0K |
| 23 | MELLANOX TECHNOLOGIES LTD | SHS | 0.48% | $625,000 | 5.6K |
| 24 | RIGEL PHARMACEUTICALS INC | COM NEW | 0.47% | $611,000 | 234.0K |
| 25 | SPRINT CORPORATION | COM | 0.47% | $608,000 | 92.5K |
| 26 | CELGCELGENE CORP | COM | 0.44% | $573,000 | 6.2K |
| 27 | NOVAVAX INC | NOTE 3.750% 2/0 | 0.40% | $521,000 | 1.32M |
| 28 | STEMLINE THERAPEUTICS INC | COM | 0.40% | $521,000 | 34.0K |
| 29 | LEXEALIBERTY EXPEDIA HLDGS INC | SER A COM | 0.40% | $521,000 | 10.9K |
| 30 | ZAYO GROUP HLDGS INC | COM | 0.39% | $510,000 | 15.5K |
| 31 | MATINAS BIOPHARMA HLDGS INC | COM | 0.38% | $492,000 | 574.6K |
| 32 | TRACON PHARMACEUTICALS INC | COM | 0.36% | $468,000 | 687.7K |
| 33 | NEMNEWMONT GOLDCORP CORPORATION | COM | 0.34% | $445,000 | 11.6K |
| 34 | ADMAADMA BIOLOGICS INC | COM | 0.33% | $430,000 | 111.0K |
| 35 | SIERRA ONCOLOGY INC | COM | 0.33% | $422,000 | 754.2K |
| 36 | ACRSACLARIS THERAPEUTICS INC | COM | 0.32% | $415,000 | 189.5K |
| 37 | GSGOLDMAN SACHS GROUP INC | COM | 0.32% | $409,000 | 2.0K |
| 38 | BABOEING CO | COM | 0.31% | $400,000 | 1.1K |
| 39 | L3 TECHNOLOGIES INC | COM | 0.30% | $392,000 | 1.6K |
| 40 | CRVSCORVUS PHARMACEUTICALS INC | COM | 0.29% | $379,000 | 101.2K |
| 41 | ADSWADVANCED DISP SVCS INC DEL | COM | 0.29% | $379,000 | 11.9K |
| 42 | ANNALY CAP MGMT INC | COM | 0.27% | $345,000 | 37.8K |
| 43 | CICIGNA CORP NEW | COM | 0.26% | $339,000 | 2.1K |
| 44 | ARRAY BIOPHARMA INC | COM | 0.23% | $301,000 | 6.5K |
| 45 | CTRLCONTROL4 CORP | COM | 0.23% | $297,000 | 12.5K |
| 46 | BELLEROPHON THERAPEUTICS INC | COM | 0.23% | $293,000 | 489.6K |
| 47 | ROSEHILL RES INC | CL A · *W EXP 04/27/202 | 0.22% | $289,000 | 131.6K |
| 48 | WFCWELLS FARGO CO NEW | COM | 0.22% | $284,000 | 6.0K |
| 49 | ENDOLOGIX INC | COM NEW | 0.22% | $283,000 | 39.1K |
| 50 | ANADARKO PETE CORP | COM | 0.22% | $282,000 | 4.0K |
| 51 | MEDIDATA SOLUTIONS INC | COM | 0.22% | $281,000 | 3.1K |
| 52 | MSFTMICROSOFT CORP | COM | 0.21% | $268,000 | 2.0K |
| 53 | ABXBARRICK GOLD CORPORATION | COM | 0.19% | $252,000 | 16.0K |
| 54 | ADPAUTOMATIC DATA PROCESSING IN | COM | 0.19% | $248,000 | 1.5K |
| 55 | COREPOINT LODGING INC | COM | 0.19% | $246,000 | 19.9K |
| 56 | AVAAVISTA CORP | COM | 0.19% | $245,000 | 5.5K |
| 57 | AMAG PHARMACEUTICALS INC | NOTE 3.250% 6/0 | 0.19% | $240,000 | 300.0K |
| 58 | RAYTHEON CO | COM NEW | 0.16% | $209,000 | 1.2K |
| 59 | UQM TECHNOLOGIES INC | COM | 0.07% | $90,000 | 54.7K |
| 60 | AMERICAN MIDSTREAM PARTNERS | COM UNITS | 0.06% | $80,000 | 15.4K |
| 61 | VACCINEX INC | COM | 0.05% | $67,000 | 12.2K |
| 62 | PACBPACIFIC BIOSCIENCES CALIF IN | COM | 0.05% | $67,000 | 11.0K |
| 63 | ARATANA THERAPEUTICS INC | COM | 0.04% | $52,000 | 10.0K |
| 64 | SUNESIS PHARMACEUTICALS INC | COM PAR | 0.03% | $44,000 | 61.0K |
| 65 | GNWGENWORTH FINL INC | COM CL A | 0.03% | $42,000 | 11.2K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2022 | $63M | 146 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $78M | 177 | Nov 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $84M | 177 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $63M | 165 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $78M | 178 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $74M | 160 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $73M | 139 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $88M | 126 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $59M | 89 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $46M | 73 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $37M | 65 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $29M | 54 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $30M | 41 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $35M | 53 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $129M | 82 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $197M | 101 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $157M | 136 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.